Keros Therapeutics, Inc. (KROS) total debt

Total debt · fiscal 2025
$16.88M

Keros Therapeutics, Inc. (KROS) carried total debt of $16.88M at the end of fiscal 2025 (December 31, 2025). That is 10.5% lower than the $18.86M of fiscal 2024. Figures as of 18 Nov 2026, 12:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$16.88M
Change on fiscal 2024
−10.5%
Highest on record
$18.86Mfiscal 2024
Lowest on record
$13.27Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Keros Therapeutics, Inc. total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $18.86M in fiscal 2024 and the lowest $13.27M in fiscal 2022.

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Keros Therapeutics, Inc. total debt, year by year

Keros Therapeutics, Inc. (KROS) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$16.88M 10.5% down0.1×
2024$18.86M 30.6% up0.0×
2023$14.44M 8.9% up0.0×
2022$13.27M—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on KROS

Keros Therapeutics, Inc., figure by figure

Keros Therapeutics, Inc. (KROS) overview: price, valuation and scorecard

Keros Therapeutics, Inc. total debt: questions and answers

How much debt does Keros Therapeutics, Inc. have?

Keros Therapeutics, Inc. (KROS) carried total debt of $16.88M at the end of fiscal 2025 (December 31, 2025). That is 10.5% lower than the $18.86M of fiscal 2024.

What are the highest and lowest total debt figures on record for Keros Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $18.86M in fiscal 2024 and the lowest $13.27M in fiscal 2022.

How does Keros Therapeutics, Inc.'s debt compare with its equity?

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

How is Keros Therapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Keros Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Keros Therapeutics, Inc. (KROS) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/KROS/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.